James Barna
CIK 1683778 · View on SEC EDGAR ↗
First SEC filing: March 3, 2023 · Latest: March 5, 2024
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 1, 2024 | DBD | A | 9,575 | — | — | 17,714 Direct | +117.64% | Acquired | (price as of 2026-08-20) |
| Jan. 19, 2024 | DBD | A | 40,696 | — | — | 40,696 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 19, 2024 | DBD | A | 8,139 | — | — | 8,139 Direct | — | Acquired | (price as of 2026-08-20) |
| Aug. 11, 2023 | DBD | J | 19,568 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-20) |
| March 8, 2023 | DBD | F | 1,071 | $3.21 | $3,438 | 19,568 Direct | -5.19% | Disposed | 1999.4% (price as of 2026-08-20) |
| Feb. 5, 2021 | DBD | A | 6,668 | — | — | 12,999 Direct | +105.32% | Acquired | (price as of 2026-08-20) |
| Jan. 30, 2021 | DBD | F | 841 | $13.66 | $11,488 | 6,331 Direct | -11.73% | Disposed | 393.3% (price as of 2026-08-20) |
| Jan. 30, 2020 | DBD | A | 7,172 | — | — | 7,172 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 19, 2024 | DBD | Employee Stock Option (right to buy) | Common Stock (40,696) | $30.90 | Jan. 19, 2034 | 40,696 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| March 3, 2023 | DBD | Common Shares | 20,639 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
DBD
CFO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $500,000 | — | $567,279 | $444,400 | $83,333 | — | $2,008,151 | $3,603,163 |
| 2023 | $472,637 | $250,000 | — | — | $413,765 | — | $15,151 | $1,151,917 |
| 2022 | — | — | — | — | — | — | — | — |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.